Novo Nordisk said on Tuesday it was working with telehealth firms Hims & Hers , Ro and LifeMD to sell Wegovy, as it looks to ...

Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of the medication.

Novo Nordisk launched access to its popular weight loss GLP-1 drug, Wegovy, through multiple telehealth platforms, including ...

Novo Nordisk, the maker of Wegovy, announced exclusively on "Good Morning America" Tuesday that the medication will soon be available for purchase through the telehealth companies Ro, Hims and ...

Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...

The pharmaceutical company announced it would be partnering with Hims & Hers., LifeMD and Ro. to provide all five dose strengths of its weight-loss GLP-1 medication Wegovy at a reduced cost of $499.

Ro teams up with Eli Lilly to offer single-dose vials of weight loss drug Zepbound Hims & Hers and Novo also said the two companies are collaborating beyond the Wegovy partnership but didn't ...

Hims & Hers Health, LifeMD, Ro, and other platforms like them will now be able to sell Novo Nordisk's Wegovy, which is used for weight loss. The blockbuster GLP-1 should entice customers.

Through NovoCare, Novo’s new direct-to-consumer pharmacy platform, Hims, LifeMD Inc., and Ro will each sell a month’s supply of Wegovy starting at $499. That’s a 63% discount from the drug ...

including Hims & Hers Health, Ro, and LifeMD. This development comes just weeks after we highlighted HIMS as a company poised for a turnaround. See - HIMS Stock: Time For A Turnaround? For those ...

As part of its deal with Novo, Hims, along with LifeMD Inc., and Ro will sell a month’s supply of Wegovy starting at $499, a 63 percent discount, before subscription fees. Lilly also announced ...